Skip to main content

Neuropathology of Dopaminergic Transplants in Patients with Parkinson’s Disease

  • Chapter
Cell Transplantation for Neurological Disorders

Part of the book series: Contemporary Neuroscience ((CNEURO))

  • 79 Accesses

Abstract

Parkinson’s disease (PD) is an idiopathic, chronic neurodegenerative disorder that predominantly affects individuals in their fifth and sixth decades of life. Clinical symptoms include tremor, bradykinesia, and rigidity, all of which invariably increase in severity as the disease progresses with time. Pathologically, there is progressive degeneration of dopaminergic neurons within the substantia nigra pars compacta. This degeneration results in pronounced deficits in striatal dopamine. The presence of laminated inclusions (Lewy bodies) is also a hallmark neuropathological feature of this disease. Palliative symptomatic treatment can be achieved by dopamine replacement therapy using the dopamine precursor, l-DOPA (Sinemet), or dopamine receptor agonists (1). However, symptomatic treatments become complicated by “wearing off effects” with disabling dyskinesias. Furthermore, as PD progresses, motor and nonmotor symptoms emerge that are not responsive to l-DOPA. Since treated patients show a life expectancy similar to that seen in age-matched controls, patients can survive with crippling symptoms for many years. Thus, new innovative treatment strategies are needed to sustain the quality of life for these individuals.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Caine, D. B. (1993) Treatment of Parkinson’s disease. NEJM 329:14, 1021–1027.

    Google Scholar 

  2. Björklund, A. and Stenevi, U. (1979) Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res. 177, 555–560.

    Article  PubMed  Google Scholar 

  3. Björklund, A., Stenevi, U., Dunnett, S. B., and Iverson, L. (1981) Functional reactivation of the deafferented neostriatum by nigral transplants. Nature 289, 497–499.

    Article  PubMed  Google Scholar 

  4. Brundin, P. and Björklund, A. (1987) Survival, growth and function of dopaminergic neurons grafted to the brain. Prog. Drain Res. 71, 293–308.

    CAS  Google Scholar 

  5. Dunnett, S. B., Björklund, A., Stenevi, U., and Iversen, S. D. (1981) Behavioral recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. Brain Res. 215, 147–161.

    Article  PubMed  CAS  Google Scholar 

  6. Dunnett, S. B., Björklund, A., Schmidt, R. H., Stenevi, U., and Iversen, S. D. (1983) Intracerebral grafting of neuronal cell suspensions IV. Behavioral recovery in rats with unilateral 6-OHDA lesions following implantation of nigral cell suspensions in different forebrain sites. Acta Physiol. Scand. S522, 29–37.

    CAS  Google Scholar 

  7. Freed, W. J., Perlow, M. J., Karoum, F., Seiger, A., Olson, L., Hoffer, B. J., et al. (1980) Restoration of dopamine brain function by grafting fetal substantia nigra to the caudate nucluss: long term behavioral, biochemical, and histological studies. Ann. Neurot. 8, 510–523.

    Google Scholar 

  8. Perlow, M. J., Freed, W. J., Hoffer, B. I., Seiger, A., Olson, L., Wyatt, R. J. (1979) Brain grafts reduce motor abnormalities produced by destruction of nigro-striatal dopamine system. Science 204, 643–647.

    Article  PubMed  CAS  Google Scholar 

  9. Kordower, J. H., Schueler. S. B., Bredesen, D., Freeman, T. B., and Sagen, J. (1994) Neural grafting for Parkinson’s disease: an evaluation of dopaminergic donor tissues, in Neural Transplantation, CNS Neuronal Injury, and Regeneration: Recent Advances (Marwah, J., Teitlebaum, H., and Prasad, H., eds. ), Boca Raton, FL, pp. 17–37.

    Google Scholar 

  10. Clarke, D.J., Brundin, P., Strecker, R., Nilsson, O., Björklund, A., and Lindvall, O. (1988) Human fetal dopamine neurons grafted in a rat model of Parkinson’s disease: ultrastructural evidence for synapse formation using tyrosine hydroxylase immunocytochemistry. Exp. Brain Res. 73, 115–126.

    Article  PubMed  CAS  Google Scholar 

  11. Brundin, P., Widner, H., Nilsson, O. G., Strecker, R. E., and Björklund, A. (1989) Intracerebral xenografts of dopamine neurons: the role of immunosuppression and the blood-brain barrier. Exp. Brain Res. 75, 195–207.

    Article  PubMed  CAS  Google Scholar 

  12. Dunnett, S. B., Hernandez, T. D., Summerfield, A., Jones, G. H., and Arbuthnot, G. (1988) Graft-derived recovery from 6-OHDA lesions: specificity of ventral mesencephalic graft tissues. Exp. Brain Res. 71, 411–424.

    Article  PubMed  CAS  Google Scholar 

  13. Freed, W. J., Morihisa, J. M., Spoor, E., Seiger, A., Olson, L., Hoffer, B. J., et al. (1981) Transplanted adrenal chromaffin cells in rat brain reduce lesion-induced rotational behavior. Nature 292, 351–352.

    Article  PubMed  CAS  Google Scholar 

  14. Freed, W. J., Cannon-Spoor, H. E., and Krauthamer, E. (1986) Intrastriatal adrenal medulla grafts in rats: long-term survival and behavioral effects. J. Neurosurg. 65, 664–670.

    Article  PubMed  CAS  Google Scholar 

  15. Stromberg, I., Herrera-Marschitz, M., Ungerstedt, U., Ebendal, T., and Olson, L. (1985) Chronic implants of chromaffin tissue into the dopamine-denervated striatum. Effects of NGF on graft survival, fiber growth and rotational behavior. Exp. Brain Res. 60, 335–349.

    Article  PubMed  CAS  Google Scholar 

  16. Date, L., Felten, S. Y., and Felten, D. L. (1990) Cografts of adrenal medulla with peripheral nerve enhance the survivability of transplanted adrenal chromaffin cells and recovery of the host nigrostriatal dopaminergic system in MPTP-treated young adult mice. Brain Res. 537, 33–39.

    Article  PubMed  CAS  Google Scholar 

  17. Date, I., Furukawa, S., and Ohmoto, T. (1994) Increased nerve growth factor level in the distal stump of transected sciatic nerve in relation to aging and its application for neural grafting. Exp. Neurol. 130, 168–171.

    Article  PubMed  CAS  Google Scholar 

  18. Date, I., Imaoka, T., Miyoshi, Y., Ono, T., Asari, S., and Ohmoto, T. (1996) Chromaffin cell survival and host dopaminergic fiber recovery in a patient with parkinson’s disease treated by cografts of adrenal medulla and pretransected peripheral nerve. J. Neurosurg. 84, 685–689.

    Article  PubMed  CAS  Google Scholar 

  19. Date, I. and Ohmoto, T. (1996) Neural transplantation and trophic factors in parkinson’s disease: special reference to chromaffin cell grafting, NGF support form pretransected peripheral nerve, and encapsulated dopamine-secreting cell grafting. Exp. Neurol. 137, 333–344.

    Article  PubMed  CAS  Google Scholar 

  20. Kordower, J. H., Fiandaca, M. S., Notter, M. F. D., Hansen, J. T., and Gash, D. M. (1990) NGF-like trophic support form peripheral nerve for grafted rhesus adrenal chromaffin cells. J. Neurosurg. 73, 418–428.

    Article  PubMed  CAS  Google Scholar 

  21. Waters, C., Itabashi, H. H., Apuzzo, M. L. J., and Weiner, L. P. (1990) Adrenal to caudate transplantation-postmortem study. Movement Disord. 5, 3–5.

    Article  Google Scholar 

  22. Hurtig, H., Joyce, J., Sladek, J. R., and Trojanowski, J. Q. (1989) Postmortem analysis of adrenal medulla to caudate autograft in a patient with Parkinson’s disease. Ann. Neurol. 25, 607–614.

    Article  PubMed  CAS  Google Scholar 

  23. Peterson, D. I., Price, M. L., and Small, C. S. (1989) Autopsy findings in a patient who had an adrenal-to-brain transplant for parkinson’s disease. Neurology 39, 235–238.

    Article  PubMed  CAS  Google Scholar 

  24. Hirsch, E. C., Duyckaerts, C., Javoy-Agid, F., Hauw, J. J., and Agid, Y. (1990) Does adrenal graft enhance recovery of dopaminergic neurons in parkinson’s disease. Ann. Neurol. 27, 676–682.

    Article  PubMed  CAS  Google Scholar 

  25. Kordower, J. H., Cochran, E., Penn, R., and Goetz, C. (1991) Putative chromaffin cell survival and enhanced host-derived Th-fiber innervation following a functional adrenal medulla autograft for Parkinson’s disease. Ann. Neurol. 29, 565–572.

    Article  Google Scholar 

  26. Jankovic, J., Grossman, R., Goodman, C., Pirozzolo, F., Schneider, L., Zhu, Z., et al. (1989) Clinical, biochemical, and neuropathologic findings following transplantation of arenal medulla to the caudate nucleus for treatment of parkinson’s disease. Neuroiogy 39, 1227–1233.

    CAS  Google Scholar 

  27. Forno, L. S. and Langston, J. W. (1991) Unfavorable outcome of adrenal medullary transplant for Parkinson’s disease. Acta Neuropathol. 81, 691–694.

    Article  PubMed  CAS  Google Scholar 

  28. Olanow, C. W., Koller, W., Goetz, C. G., Stebbins, G. T., Cahill, D. W., Gauger, L. L., et al. (1990) Autologous transplantation of adrenal medulla in Parkinson’s disease. Arch. Neurol. 47, 1286–1289.

    Article  PubMed  CAS  Google Scholar 

  29. Bankiewicz, K. S., Plunkett, R. J., Kopin, I. J., London, W. T., and Oldfield, E. H. (1988) Transient behavioral recovery in hemiparkinsonian primates after adrenal medullary autografts, in Transplantation into the Mammalian CNS (Gash, D. M. and Sladek, J. R., Jr., eds.), Prog. Brain Res. 78, 543–550.

    Google Scholar 

  30. Bankiewicz, K. S., Plunkett, R. J., Jacobowitz, D. M., Porrino, L., di Pordo, U., London, W. T., et al. (1990) The effect of fetal mesencephalon implantation primate MPTP-induced parkinsonism. Histochemical and behavioral studies. J. Neurosurg. 7, 231–244.

    Google Scholar 

  31. Hansen, J. T., Kordower, J. H. Fiandaca, M. S., Notter, N. F. D., and Gash, D. M. (1988) Adrenal medullary autografts into the basal ganglia of cebus monkeys: graft viability and fine structure. Exp. Neurol. 102, 65–76.

    Article  PubMed  CAS  Google Scholar 

  32. Morihisa, J. M., Nakamura, R. K., Freed, W. J., Mishkin, M., and Wyatt R. J. (1984) Adrenal medulla grafts survive and exhibit catecholamine-specific fluorescence in the primate brain. Exp. Neurol. 84, 643–651.

    Article  PubMed  CAS  Google Scholar 

  33. Schueler, S. B., Ortega, J. S., Sagen, J., and Kordower, J. H. (1993) Robust survival of isolated bovine adrenal chromaffin cells following intrastriatal transplantation: a novel hypothesis of adrenal graft viability. J. Neurosci. 13, 4496–4510.

    PubMed  CAS  Google Scholar 

  34. Schueler, S. B., Sagen, J., Pappas, G. D., and Kordower, J. H. (1995) Long-term viability of isolated bovine adrenal medullary chromaffin cells following intrasiatal transplantation. Cell Transplantation 4 (1), 55–64.

    Article  PubMed  CAS  Google Scholar 

  35. Bohn, M. C., Cupit, L., Marciano, F., and Gash, D. M. (1987) Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers. Science 237, 913–915.

    Article  PubMed  CAS  Google Scholar 

  36. Fiandaca, M. S., Kordower, J. H., Hansen, T. T., Jiao, S.-S., and Gash, D. M. (1988) Adrenal medullary autografts into the basal ganglia of Cebus monkeys: injury-induced regeneration. Exp. Neurol. 102, 76–91.

    Article  PubMed  CAS  Google Scholar 

  37. Stromerg, I., Herrera-Marschitz, M., Ungerstedt, U., Ebendal, T., and Olson, L. (1985) Chronic implants of chromaffin tissue into the dopamine-denervated striatum. Effects of NGF on graft survival, fiber growth and rotational behavior. Exp. Brain Res. 60, 335–349.

    Google Scholar 

  38. Olson, L., Backlund, E.-O., Ebendal, T., Freedman, R., Hamberger, B., Hansson, P., et al. (1991) Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson’s disease. Arch. Neurol. 45, 373–381.

    Article  Google Scholar 

  39. Kordower, J. H., Felten, D. L., and Gash, D. M. (1992) Dopaminergic transplants for Parkinson’s disease, in Scientific Basis for Therapy in Parkinson’s Disease ( Olanow, C. W., ed.), Parthenon, Lanes, pp. 175–224.

    Google Scholar 

  40. Watts, R. L., Mandir, A. S., and Bakay, R. A. (1995) Intrastriatal cografts of autologous adrenal medulla and sural nerve in MPTP-induced parkinsonian macaques: behavioral and anatomical assessment. Cell Transplantation 4 (1), 27–38.

    Article  PubMed  CAS  Google Scholar 

  41. Watts, R. L., Freemann, A., and Goetz, C. G. (1993) Autologous intrastriatal adrenal medulla/nerve co-graft in Parkinson’s disease (PD): early results. Neurology 43 (2), A222.

    Google Scholar 

  42. Date, I., Imaoka, T., Miyoshi, Y., Ono, T., Asari, S., and Ohmoto, T. (1996) Chromaffin cell survival and host dopaminergic fiber recovery in a patient with parkinson’s disease treated by cografts of adrenal medulla and pretransected peripheral nerve. J. Neurosurg. 84, 685–689.

    Article  PubMed  CAS  Google Scholar 

  43. Redmond, D. E., Jr., Leranth, C., Spencer, D. D., Robbins, R., Vollmer, T., Kim, J. H., et al. (1990) Fetal neural graft survival. Lancet 336, 820–822.

    Article  PubMed  Google Scholar 

  44. Folkerth, R. D. and Raymon, D. (1996) Survival and proliferation of nonneural tissues, with obstruction of cerebal ventricles, in a parkinsonian patient treated with fetal allografts. Neurology 116, 1219–1224.

    Article  Google Scholar 

  45. Rosenstein, J. M. and Brightman, M. W. (1986) Alterations of the blood brain barrier after transplantation of autonomic ganglia into the mammilian central nervous system. J. Comp. Neurol. 253 (3), 335–351.

    Google Scholar 

  46. Freeman, T. B., Olanow, C. W., Hauser, R. A., Nauert, G. M., Smith, D. A., Borlongan, C. V., et al. (1995) Bilateral fetal nigral transplantation into the post-commissural putamen as a treatment for Parkinson’s disease: six month follow-up. Ann. Neurol. 38, 379–388.

    Article  PubMed  CAS  Google Scholar 

  47. Kordower, J. H., Freeman, T. B., Snow, B. J., Vingerhoets, F. J. G., Mufson, E. J., Sanberg, P. R., et al. (1995) Neuropathological evidence fo graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with parkinson’s disease. N. Engl. J. Med. 332 (17), 1118–1124.

    Article  PubMed  CAS  Google Scholar 

  48. Kordower, J. H., Rosenstein, J. M., Collier, T. J., Burke, M. A., Chen, E.-Y., Li, J. M., et al. (1996) Functional fetal nigral grafts in a patient with Parkinson’s disease: chemoanatomic, ultrastructural, and metabolic studies. J. Comp. Neurol. 370, 203–230.

    Article  PubMed  CAS  Google Scholar 

  49. Kordower, J. H., Rosenstein, J. M., Collier, T. J., Chen, E.-Y., Li, J.-M., Mufson, E. J., et al. (1996) Functional fetal nigral grafts in a second patient with Parkinson’s Disease: a post-mortem analysis. Movement Disorders,in press.

    Google Scholar 

  50. Deacon, T. Thomas, C., Dinsmore, X., Palmer, E. P., Penney, D., Kott, S., et al. (1996) Post-mortem histological characterization of surviving porcine mesencephalic cell suspension xenografts in a parkinsonian patient. Soc. Neurosci. Abstracts 22, 318.

    Google Scholar 

  51. Freeman, T. B., Sanberg, P. R., Nauert, G. M., Borlongan, C., Liu, E.-Z., Boss, B. D., et al. (1995) The influence of donor age on the survival of solid and suspension intraparenchymal human embryonic nigral grafts. Cell Transplantation 4, 141–154.

    Article  PubMed  CAS  Google Scholar 

  52. Olanow, C. W., Kordower, J. H., and Freeman, T. B. (1996) Fetal nigral transplantation as a therapy for Parkinson’s disease. Trends Neurosci. 19, 102–109.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Kordower, J.H., Hanbury, R., Bankiewicz, K.S. (1998). Neuropathology of Dopaminergic Transplants in Patients with Parkinson’s Disease. In: Freeman, T.B., Widner, H. (eds) Cell Transplantation for Neurological Disorders. Contemporary Neuroscience. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-476-4_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-476-4_5

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-043-4

  • Online ISBN: 978-1-59259-476-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics